1Leel CW, Sarnal SK,Singaramc, et al. Ca^2+ channel blockade by verapamil inhibits GMCs and diarrhea during small intestinal inflammation. Am J Physiol, 1997, 273 (4 pt 1): 785.
2Matsubara M, Hasegcuna K. Effects of benidipine,a dihydl'opyridine-Ca^2+ channel blockes, on expression of cytokineinduced adhesion moleaules and chemoatlractants in human aortic endothelial cells. Eur J Pharmacol, 2004, 498(1-3): 303.
3Folts JD. inhibition of platelet activity in vivo by andodipine alone and combined with aspirin, lnt J Cardiol,1997,62(suppl 2): S111.
4Chou TC,Li CY,Yen MH,et al. Antiplatelet effects of amlodpine: a possible mechanism through a nitric oxide mediated process. Biochem Pharmacol, 1999, 58(10):1657.
5Leng ttS,Yao X, Leang FP,et al. Cilnidipine, a low-aoting Ca^2+ channel blooker, induces relaxation in porcine coronary artery: role of endathelial nitric oxide and [Ca^2+]i, Br J Pharmacol,2006, 147(1):53.
7Palor M, Guralnik JM, Furberg CD,et al. Risk of gastrointestinal haemorrage with calcium antagonist in hypertensive persons over 67 years old. Lancet, 1996. 347.
8Lacost LL, Lain JYT, Huang J, et al. Oral veralpamil inhibits platelet thrombus formation in humans. Circulation, 1994,89:630.
10Jackson CL,Bush RC,Bowyer DE. Mechanism of antiatherogenic action of calcium antagonists. Atheroselerosis, 1989,80(1):17.
二级参考文献16
1Lake-bakaar G, Lyubsky S. Dose-dependent effect of continuous subcutaneous verapimal infusion on experimental acute pancreatitis in mice. Dig Dis Sci,1995,40:2349-2354.
2Iida T, Yokoi H, Kawarada Y. The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin 12 analogue on experimental acute necrotizing pancreatitis in rats. Pancreas, 1998,17:140-147.
3Karne S, Gorelick FS. Etiopathogenesis of acute pancreatitis.Surg Clin North Am, 1999,79:699.
7Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993:362 (6423): 801-9.
8Soma MR, Natali M, Donetti E, et al. Effect of lercanidipine and its(R) -enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits. Br J Pharmacol 1998;125(7):1471-6.
9Tulenko TN, Brown J, Laury-Kleintop L, et al. Atheroprotecction with amlodipine:cells to lesions and the PREVENT trial. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial. J Cardiovasc Pharmacol 1999;33:S17-S22.
10Zanchetti A, Bond MG, Hennic M, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis(ELSA), a randomized, double-blind,long-term trial. Circulation 2002; 106(19):2422-7.
